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Abstract
Background: Families of paralogous oligomeric proteins are common in biology. How the specificity of assembly evolves is
a fundamental question of biology. The LysR-Type Transcriptional Regulators (LTTR) form perhaps the largest family of
transcriptional regulators in bacteria. Because genomes often encode many LTTR family members, it is assumed that many
distinct homooligomers are formed simultaneously in the same cell without interfering with each other’s activities,
suggesting specificity in the interactions. However, this assumption has not been systematically tested.
Methodology/Principal Findings: A negative-dominant assay with lcI repressor fusions was used to evaluate the assembly
of the LTTRs in E. coli K-12. Thioredoxin (Trx)-LTTR fusions were used to challenge the homooligomeric interactions of lcI-
LTTR fusions. Eight cI-LTTR fusions were challenged with twenty-eight Trx fusions. LTTRs could be divided into three classes
based on their interactions with other LTTRs.
Conclusions/Significance: Multimerization of LTTRs in E. coli K-12 is mostly specific. However, under the conditions of the
assay, many LTTRs interact with more than one noncognate partner. The physiological significance and physical basis for
these interactions are not known.
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Introduction
The LysR-Type Transcriptional Regulators (LTTRs) are a
diverse family of oligomeric bacterial transcription factors. Initially
identified by Henikoff et al., their number has grown to over 40,000
potential members (IPR000847 HTH_LysR) as of this writing,
making it perhaps the largest family of transcriptional regulators
among prokaryotes [1,2]. Characterized LTTRs regulate a wide
variety of transcription units in response to a wide variety of
environmental signals. In E.coli K-12 LTTRs regulate nitrogen
source utilization, amino acid biosynthesis and catabolism,
oxidative stress response and detoxification of the cell [3,4]. BenM
and CatM both affect aromatic compound degradation in
Acinetobacter sp. strain ADP1 [5,6]. RovM of Yersinia pestis, MvfR
of Pseudomonas aeruginosa PA14, and AphB of Vibrio cholerae have all
been shown to be involved in virulence [7,8,9,10].
As a large family of oligomeric proteins presumably derived from
a commonancestor,the LTTRsprovide an excellent opportunityto
investigate the evolution of protein self-assembly. Those LTTRs
that have been characterized so far form homooligomers, consisting
mostlyoftetramersandinsomecases,dimers[1,3,11].Examination
of the available crystal structures of full-length LTTRs and a larger
number of oligomeric regulatory domains shows an overall
structural similarity, with the interactions being essential for
function of the protein [12,13,14,15,16,17].
The number of LTTRs in a given species is highly variable. For
example, the E coli K-12 strain MG1655 has 47 members, while
Pseudomonas aeruginosa PA01 has 121 members (COG0583 [18]). By
contrast, LTTRs are absent from the genome of H. pylori.I n
species with large numbers of LTTRs, it could be potentially
detrimental if all combinations of LTTRs formed heteromulti-
mers, suggesting that there is a strong selective pressure for
complex formation to be highly specific. However, the specificity
of the oligomerization by LTTRs has not been explicitly tested. In
this study, we utilize lcI repressor LTTR fusions in a negative-
dominance assay [19] to examine whether LTTRs from E. coli
form promiscuous heterotypic interactions.
Results
A Negative-Dominance System with l repressor and
Thioredoxin Fusions
The basic idea of our assay is shown in Figure 1. A subset of the
E. coli LTTRs are able to drive oligomerization of the l repressor
N-terminal DNA-binding domain at levels sufficient to confer
immunity to infection by bacteriophage l. Overexpression of a
competing oligomerization domain that is not fused to the DNA
binding domain of l cI will render cells sensitive to l if formation of
heteromultimers reduces the intracellular level of homomultimeric
repressorfusionsbelowtheamountneeded torepressinfectingphage.
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repressor fusions utilized two constructs: a l cI repressor fusion
that could homooligomerize and a l cI repressor fusion with a
mutation in the helix-turn-helix DNA binding domain that
abolished binding of the fusion to DNA [19]. Instead of the latter
construct, we utilized a thioredoxin (Trx) fusion that was under the
control of ParaBAD.
LTTRs with the ability to oligomerize as l cI repressor fusions
were initially identified in a large scale screen of the E. coli genome
[20]. We challenged eight of these l cI-LTTR repressor fusions
with their Trx-LTTR fusion counterparts, using fusions to the
yeast GCN4 leucine zipper domain, Trx-GCN4 and lcI-GCN4,
as controls. This small set of interactions is outlined in the black
box in Figure 2. The Trx-GCN4 did not interact with any
repressor fusions except l cI-GCN4. l cI-GCN4 did not interact
with any other thioredoxin fusion except GCN4 (not shown).
All l cI -LTTR proteins interacted with their respective
thioredoxin fusion, as indicated by the black boxes in Figure 2.
Surprisingly, some heterotypic interactions were observed, partic-
ularly with the Trx-HdfR fusion against l cI -YafC, l cI -CynR
and l cI -YiaU, as indicated by the gray boxes.
Expansion of the Grid
We next tested the l cI-LTTR fusions against 20 other Trx-
LTTR fusions. The resultant interactions are shown in Figure 2.
Several Trx-LTTR fusions had numerous interactions with the l
cI-LTTR fusions, including Trx-Cbl, -OxyR, -PerR and -YbeF.
Others, such as LysR, NhaR and YneJ showed only one or two
interactions. Many showed no interactions with the l cI-LTTR
fusions tested.
Results of Both Grids
Of the 216 potential heterotypic interactions, 37 were detected,
which allowed the LTTRs to be divided into 3 classes: I) those
whose Trx-LTTRs did not interact with any others, II) LTTRs
whose Trx fusions formed only one or two interactions (CynR,
LysR, NhaR, YneJ and YiaU), and III) LTTRs whose Trx fusions
were promiscuous in their interactions with other LTTRs (Cbl,
OxyR, PerR, YbeF and YdaK). Note, however, that all eight cI
fusions interact with at least three noncognate Trx fusions.
Phylogenetic analysis
We used the phylogenetic tree from PFAM for the LysR
substrate domain (PF03466) to examine the evolutionary relation-
ships between the LTTRs used in this study. The average pairwise
branch lengths separating all pairs of E. coli LTTRs, members of
the tested set, and the interacting pairs were 2.5160.45,
2.5260.40, and 2.416.43, respectively.
Discussion
Coupling the assembly of LTTRs to the DNA binding activity
of phage l repressor allowed us to use a single assay based on
negative dominance to perform pair-wise testing of 216 potential
interactions among LTTRs that normally recognize different
DNA sequences.
With the caveats discussed below, the overall pattern we
observed is consistent with the idea that evolution selects for
diversification of assembly specificity within families of paralogous
proteins. Although most LTTRs (class I) have few detectable
interactions with the other tested LTTRs, cross-interactions are
observed and none of the cI-LTTR fusions was resistant to all of
the noncognate Trx-LTTR fusions. Since we could not test all
combinations, we cannot tell whether the LTTRs whose Trx
fusions were in class I interact with other noncognate LTTRs.
Figure 1. Negative-dominance Assay. The oligomerizing cI fusion
is shown on the left-hand side. The proteins tested for heterotypic
interactions are represented by the colored spheres. Proteins that can
form heterotypic interactions with the immune cI fusion generate a
sensitive phenotype. Those that can not form an interaction remain
immune.
doi:10.1371/journal.pone.0015189.g001
Figure 2. Interaction Grid of the LTTRs. On the left are the immune l cI repressor fusions. Across the top are the Trx-LTTR fusion constructs. The
type of interaction between two proteins is denoted by a shaded square. Black is representative of a homotypic interaction, while gray is a
heterotypic interaction. White indicates no interaction was detected.
doi:10.1371/journal.pone.0015189.g002
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either specific or nonspecific protein-protein interactions. Non-
specific interactions could affect only a subset of partners if
different cI-LTTRs vary in their sensitivity to such nonspecific
effects. For example, LTTRs with intrinsically weaker multi-
merization would be more sensitive to a nonspecific competitor.
We would expect that such nonspecific mechanisms would show a
hierarchy where, although different cI fusions would react with
different subsets of the Trx fusions, the fusions could be ranked in
terms of both the ability of the Trx fusions to elicit the nonspecific
effect, and the sensitivity of the cI fusions to the effect. The
patterns of inhibition seen with the class II and class III Trx-
LTTRs are inconsistent with a single nonspecific mechanism of
this kind.
The class III Trx-LTTR fusions collectively interact with all
eight of the cI fusions, but there seems to be no obvious pattern for
which cI fusions are sensitive to the overexpression of each class III
Trx fusion. Within the subset of possible interactions we could test,
the pattern of cross-interaction also does not seem to fall into
disjoint clusters, as we might expect if specific interactions behaved
as stable traits over the evolution of the LTTR family.
This lack of pattern suggests that the cross-interaction among
LTTRs may reflect independent evolution of interactions, which
need not even involve the same interface residues. Consistent with
this view, phylogenetic analysis of interacting and noninteracting
pairs showed no evidence that the interactions we observed are
generally correlated with evolutionary distance. Although half of
the eight cI fusions did interact with their closest relative, all of
them interacted with LTTRs that are more distantly related than
proteins with which they failed to interact in our assay. This is not
surprising for the highly divergent paralogs we tested with pairwise
sequence identies ranging from 5.45% (yiaU vs cysB) to 33.1%
(perR vs gcvA).
Previous systematic studies of oligomerization in OxyR and
CynR, showed that although the surfaces involved in homodimer-
ization of their regulatory domains are superficially similar, distinct
residues and residue interactions are important for oligomerization
of these LTTRs [21,22]. Cross-interactions could thus reflect the
plasticity of subunit interfaces, allowing evolution to find different
combinations of interactions to build similar quaternary structures.
The physiological significance of the cross-interactions is
unclear. It is formally possible that heteromultimeric LTTRs form
functional transcription factors with different physiological roles
from the homomultimers. However, we do not think this is likely
in most cases of cross-interaction. Formation of heteromultimers
could interfere with the normal function of LTTRs, just as it
interferes with the l repressor fusions. However, it is likely that
some heteromultimerization can be tolerated. Our assay cannot
determine the relative affinities of LTTRs homomultimers vs.
heteromultimers, so it is possible that homomultimers are favored
and heteromultimers are only observable under our artificially
high overexpression of the Trx fusions. But even if homomultimers
and heteromultimers form with equal affinity, note the concen-
tration of inhibitors in vivo may be inadequate to have a significant
inhibitory effect. Transcription factors are often expressed at low
steady state levels, of the thirty-eight LTTRs we examined, only
two had detectable peptides in a mass-spectrometry based catalog
of protein abundance in E. coli [23].
As with all fusion-based systems, ours has limitations and is likely
to have false positives and false negatives. Negative dominance
occurs only if the inhibitory heteromultimerization can drive the
concentration of an active homomultimeric cI fusion below the
threshold needed to to block phage infection. Empirically, we find
that this requires a large excess of the inhibitory Trx fusion to drive
the equilibrium depicted in Figure 1 far enough to the right.
However, the expression system used for the Trx-LTTR fusions
could besofarabovephysiologicalconcentrationsofthe LTTR that
interactions that are not biologically relevant might be detected; the
physiological levels of each native LTTR has not been determined.
However,differencesinthe expression ofthe Trx-LTTRsisunlikely
to account for the differences in promiscuity of the observed
interactions. The fusions are C-terminal fusions that use the same
transcriptionand translationsignalsfortheirexpression.Inthecases
where we have examined accumulation of the fusion proteins after
induction, the proteins accumulated to similar levels (data not
shown).
Methods
Construction of Fusions
cI-LTTR fusions. Plasmid-borne lambda cI-LTTR fusions
that confer immunity to infection by phage lambda (left column of
grid in Figure 2) were previously identified in a screen for
homotypic interactions in E. coli K-12 [20]. Each of these fusion
proteins contains the DNA-binding domain of l cI Repressor
fused to a full-length (or almost full-length) LTTR protein. These
are expressed from a plasmid vector that carries ampicillin
resistance and has the M13 single-strand replication origin [24].
Trx-LTTR fusions. Plasmid-borne Trx-LTTR fusions were
constructed using the Gateway (Invitrogen) system. For cynR,
gcvA, iciA, ilvY, pssR, yafC, yiaU, and ynfL, the cI fusions
described above were used as PCR template DNA. These LTTR
genes were amplified using Pfx Platinum DNA polymerase
(Invitrogen) and primers attB1 and attB2 (PAGE purified, IDT,
Iowa), which attach Gateway cloning sites. The sequences of the
primers were: attB1:5 9 GGG GAC AAG TTT GTA CAA AAA
AGC AGG CTA CAA GGA CGA CGA TGA CAA G 39; attB2:
59 GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC
TTT CGG GCT TTG TTA GCA G 39. The sizes of the
amplified products were verified by agarose (1% in TBE) gel
electophoresis.
The other ORFs were obtained as plasmids from plasmids
obtained from H. Mori (Keio University) in the Gateway
destination vector pAZ20. pAZ20 is a modified version of
pLM1000 [25] in which the amber stop codon between the lcI
DNA-binding domain and the attL Gateway site was removed and
a SfiI site was created between the Gateway sites via site-directed
mutagenesis. After purification using the Qiagen PCR Clean-up
Kit, each PCR product was recombined into pDONR201
(Invitrogen) using the Gateway BP reaction and transformed into
either E. coli K-12 MC1061 [26] or Mach T1 (Invitrogen).
Trx-LTTR fusion plasmids were constructed by Gateway attL-
attR reaction between these entry clones and plasmid pJM198
(this study). pJM198 is derived from pBAD-DEST49 (Invitrogen),
where the origin of replication and ampicillin resistance gene are
replaced by the origin and tetracycline resistance gene from
pACYC184.
Negative-Dominant Assay
We modified the negative-dominance assay based on the l cI
repressor system developed by Zeng et al. [19] to detect protein-
protein interactions. As illustrated in Fig. 1, the wild-type DNA-
binding domain of l cI is fused to an LTTR protein that can
oligomerize the DNA-binding domain and confer immunity to
infection by l, even when the cI
+-LTTR fusion protein is
transcribed from a weak, constitutively expressed promoter. When
a second construct encoding the same LTTR protein now fused to
thioredoxin (Trx) is introduced to the cells and the fusions protein
LysR-Type Regulator Oligomerization Specificity
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+-LTTR homo-
oligomers is decreased by the formation of cI
+-LTTR/Trx-LTTR
heterooligomers and the cells become sensitive to l infection. The
ability of different LTTR proteins to form heteroligomers in vivo
was tested using pairwise combinations of cI
+ and Trx fusion
proteins.
Construction of Double Strains
Strains containing the two plasmid constructs to be tested were
constructed using M13 transduction. Bacteriophage M13 RV-1
was used to package the plasmids carrying the immune l cI-
LTTR fusions. Lysates were made on strains growing in 2XYT
plus ampicillin (200 mg/mL). Recipient strains containing the Trx-
LTTR fusions were grown overnight in 2XYT plus tetracycline
(20 mg/mL). Approximately 50 ml of the recipient cultures was
transferred to the wells of a sterile 96-well plate followed by the
addition of 5 mL of the appropriate M13 lysate. After incubation
for 10 min at room temperature, 100 mL of LB was added to each
well, and the plate was covered with Airpore tape (Qiagen). After
2 h incubation at 37uC, cells containing both plasmids were
selected by using a 96-prong frogger to transfer cells to LB plates
containing ampicillin and tetracycline. After overnight incubation
at 37uC, the entire grid was stamped onto fresh LB-ampicillin-
tetracycline plates and once again incubated overnight at 37uC.
Cells were taken from these spots and tested for immunity by
cross-streaking as described below.
Cross-streak Assays
Cross-streak assays were performed to assay the ability of a Trx-
LTTR fusion protein and a cI-LTTR fusion protein to form
heterooligomers. Briefly, parallel lines of phage lKH54 and li
21c
were drawn on plates containing tryptone broth (TB) medium, TB
+0.2% glucose, or TB +0.2% arabinose and allowed to soak into
the plate. Colonies of strains to be tested were dragged across the
lines of phage. Plates were incubated at 37uC for six hours and the
phenotype noted. Fusion proteins that can form heterotypic
interactions will be sensitive to l if the cI
+ homooligomer levels fall
below the critical level required for immunity to lKH54 and thus
have a sensitive phenotype. Immunity to l is scored when the cI
+/
cI
+ complex is more stable than a cI
+/cI
2 complex.
Phylogenetic analysis
A phylogenetic tree built from the LysR substrate domain
(PF03466) of 33481 entries was downloaded from PFAM (http://
pfam.sanger.ac.uk/family/PF03466#tabview=tab4) [27] as a
Newick formatted text file. A BioPerl script was used to extract
pairwise distances between nodes for all of the E. coli LTTRs.
Distributions of these distances were analyzed using Microsoft
Excel. Pairwise amino acid identity was calculated using multiple
sequence alignment with T-Coffee [28].
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